Results 251 to 260 of about 468,247 (310)

Migration Governance Through Funding: Theoretical, Normative, and Empirical Perspectives. [PDF]

J Immigr Refug Stud
Tsourdi EL, Zardo F.
europepmc   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Financing marketing with EU funds

Transactions of the Institute of Aviation, 2012
openaire   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source

Fertility, family planning, pregnancy and motherhood among women doctors working in the EU and UK: a scoping review. [PDF]

BMJ Open
Biju S, Madden C, O'Connor P, Byrne D, Humphries N, Jeffrey G, Finnegan J, O'Donoghue K, Fitzgibbon S, Lydon S.   +9 more
europepmc   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

Molecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad, Marie Austdal, Oddmund Nordgård, Gunnar Mellgren, Satu Oltedal, Marie L. Austbø, Ylva H. Vignes, Thomas Helland, Kristin Jonsdottir, Tone H. Lende, Emilius A. M. Janssen, Bjørnar Gilje, Kjersti Tjensvoll, PBCB study group, Gunnar Mellgren, Tone Hoel Lende, Anette Heie, Kristin Viste, Anita Røyneberg Alvheim, Emiel AM Janssen, Kristin Jonsdottir, Ann Cathrine Kroksveen, Thomas Helland, Einar Gudlaugsson, Oddmund Nordgård, Satu Oltedal, Kristin Løge Aanestad, Jan Terje Kvaløy, Kirsten Lode, Kari Britt Hagen, Marie Austdal, Ylva H. Vignes, Siri Tungland Sola, Nina Egeland Amundsen, Finn Magnus Eliassen, Emeritus Ernst A Lien   +35 more
wiley   +1 more source

Northern Peatlands in Transition in the 21st Century - Land Use, Status, Policies and Future Trajectories: Comparisons Between Finland, Ireland and Scotland. [PDF]

Environ Manage
Lampela M, Renou-Wilson F, Andersen R, Wilson D, Artz RRE, Clilverd H, Turunen J, Tolvanen A, Maanavilja L, Laine AM.   +9 more
europepmc   +1 more source

EU funds bio-isobutene consortium

Focus on Catalysts, 2017
openaire   +1 more source

Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience. [PDF]

Kidney Int Rep
Angeletti A, Caridi G, Kajana X, Bigatti C, Spennacchio A, Chiarenza DS, Mortari G, Cravedi P, Verrina EE.   +8 more
europepmc   +1 more source

To patent or not to patent: challenges and solutions to the patent ban on new genomic techniques plant in EU. [PDF]

GM Crops Food
Jiang L, Adcock M, Yang H.
europepmc   +1 more source